Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2026-02-03 @ 9:32 PM
Study NCT ID:
NCT00623766
Status:
COMPLETED
Last Update Posted:
2014-06-09
First Post:
2008-02-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
Keywords: